A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)

Clinical trial NCT03783923 · TERMINATED

Trial details

NCT number: NCT03783923
Sponsor: PTC Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Limb-Girdle Muscular Dystrophy

Start date: 2019-10-31
Primary completion: 2021-01-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.